α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease-Reference-Cited by-同舟云学术

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease

Published:2004-03 Issue:3 Volume:10 Page:204-212
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Posthuma Eduardus F.M,Marijt Erik W.A.F,Barge Renee M.Y,van Soest Ronald A,Baas Inge O,Starrenburg C.W.J.Ingrid,van Zelderen-Bhola Shama L,Fibbe Willem E,Smit Wim M,Willemze Roel,Falkenburg J.H.Frederik

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference31 articles.

1. Chronic myeloid leukemia;Sawyers;N Engl J Med.,1999

2. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion;Goldman;Ann Intern Med.,1988

3. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients;Kolb;Blood,1990

4. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation;Collins;J Clin Oncol.,1997

5. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia;Kolb;Blood,1995

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving outcomes of hematopoietic stem cell transplant for leukemia in children and young adults in resource-limited setting;Pediatric Hematology Oncology Journal;2024-06

2. The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy;Frontiers in Immunology;2024-03-15

3. MSCs interaction with the host lung microenvironment: An overlooked aspect?;Frontiers in Immunology;2022-11-15

4. Comparison of Outcomes of Donor Lymphocyte Infusions With or Without Lenalidomide in Patients with Hematological Malignancies Post Allogeneic HSCT;Indian Journal of Hematology and Blood Transfusion;2022-07-22

5. Interferon maintenance for prevention of relapse in favorable risk AML?;Leukemia & Lymphoma;2021-09-03